The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)December 18, 2025 — Researchers searching for better ways to treat ovarian cancer have reported encouraging results from laboratory tests involving two marijuana compounds. According to a new study, both THC and CBD were able to slow the growth of ovarian cancer cells, and when used together, they were particularly effective at killing existing malignant cells.
December 18, 2025 — Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.
December 18, 2025 — Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include a paid advertisement.
December 18, 2025 — Disseminated on behalf of Ucore Rare Metals Inc. (TSX.
December 18, 2025 — Beeline Holdings (NASDAQ: BLNE) reported strong Q3 2025 performance, with revenue growth of 37% and a 9% decrease in operating expenses, underscoring its progress toward profitability and scale. An article discussing this reads, “A major contributor to Beeline’s growing pipeline is BeelineEquity, the company’s fractional home-equity sale platform built on blockchain infrastructure.
December 18, 2025 — Disseminated on behalf of SPARC AI Inc. and may include paid advertising.
December 18, 2025 — Robo. ai (NASDAQ: AIIO) announced it has entered into definitive financing agreements with ATW Partners totaling $180 million, consisting of $80 million in convertible notes and a $100 million equity purchase facility, with the first tranche completed on Dec.
December 18, 2025 — This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.
December 18, 2025 — FG Nexus (NASDAQ: FGNX, FGNXP) announced an update on its common stock buyback program and digital asset holdings, reporting that it repurchased approximately 7. 0 million shares at an average price of about $3.
December 18, 2025 — Datavault AI (NASDAQ: DVLT) CEO Nathaniel T. Bradley appeared on Newsmax to discuss the Trump administration’s approval of plans to launch the first group of cryptocurrency-focused national banks, a move aimed at expanding the crypto industry’s access to the traditional financial system.
December 18, 2025 — SKYX Platforms (NASDAQ: SKYX) announced it will launch its newly patented all-in-one ceiling plug-and-play SKYFAN and Turbo Heater at U. S.
December 18, 2025 — Chairman and CEO Moishe Gubin used his NobleCon21 presentation to outline Strawberry Fields REIT’s disciplined expansion strategy and long-term approach to healthcare real estate. The company now holds long-term leasehold interests in 142 healthcare facilities with more than 15,500 licensed beds across 10 states.
December 18, 2025 — Safe Pro Group (NASDAQ: SPAI) announced that its board of directors has authorized a share repurchase program of up to $3. 0 million of the company’s outstanding common stock over the next year, citing confidence in its strategy, AI-enabled defense and security technology platform, and long-term growth opportunities.
December 18, 2025 — Massimo Group (NASDAQ: MAMO) announced the launch of a dedicated Fleet and Commercial Vehicle Program, marking a strategic expansion beyond traditional retail sales and targeting fleet-oriented customers such as security operations, municipalities, campuses, grounds maintenance providers, and commercial facilities. The manufacturer and distributor of powersports and electric vehicles said the program will initially focus on its newly introduced MVR HVAC electric vehicle series, which features fully enclosed cabs with heating and air conditioning designed for high-utilization, year-round operation, with a structured go-to-market strategy that includes direct fleet engagement, trade show participation, and dedicated commercial sales efforts to support repeat purchasing and long-term customer relationships.
December 18, 2025 — This article has been disseminated on behalf of Foremost Clean Energy Ltd. and may include paid advertising.
December 18, 2025 — BluSky Ai (OTCID: BSAI), a developer of artificial intelligence infrastructure software, was the subject of a December 2025 independent research report published by Globe Small Cap Research LLC that reviewed the company’s distributed GPU-centric AI platform and its potential role in addressing growing demand for scalable compute resources. The report examines BluSky Ai’s centralized cloud software architecture designed to aggregate geographically dispersed GPU modules into a single elastic pool, enabling enterprises and public-sector users to deploy AI workloads without relying solely on traditional centralized data centers.
December 18, 2025 — A central pillar of Search Mineral’s commitment to the community is its long-standing partnership with the NunatuKavut Community Council The company further reinforces this partnership through its governance structure Search Minerals also maintains frequent dialogue with leaders in St. Lewis, Mary’s Harbour and Port Hope Simpson Disseminated on behalf of Search Minerals Inc.
December 18, 2025 — GlobalTech (OTC: GLTK) announced the closing of its previously disclosed definitive agreement to acquire a 51% controlling interest in 123 Investments Limited, doing business as Moda in Pelle, a premium U. K.
December 18, 2025 — Forward Industries (NASDAQ: FWDI) announced that its SEC-registered shares are now live on the Solana blockchain through Superstate’s Opening Bell platform, marking the first time a public company’s equity can be used directly within decentralized finance, with tokenized FWDI shares available for eligible ex-U. S.
December 18, 2025 — Telomir Pharmaceuticals (NASDAQ: TELO) announced favorable results from a comprehensive series of IND-enabling Good Laboratory Practice toxicology and safety pharmacology studies for its lead therapeutic candidate Telomir-1 (Zn-Telomir), reporting no treatment-related adverse or dose-limiting toxicities across cardiovascular, respiratory, phototoxicity, and repeat-dose evaluations in both rodent and non-rodent models. The preclinical-stage biotechnology company said Telomir-1 was well tolerated with no concerning cardiac or respiratory safety signals, no phototoxic potential, and only limited, reversible, and non-adverse findings in repeated-dose studies, while demonstrating consistent systemic exposure and predictable pharmacokinetics following oral administration, supporting continued advancement toward first-in-human clinical development pending completion of final quality assurance review and applicable regulatory pathways.